PT-141 (BREMELANOTIDE)
For Him & Her Sexual Wellness

PT-141 (BREMELANOTIDE)

10k+ verified patient reviews

Injectable bremelanotide treatment with licensed provider oversight and an individualized care plan.

Program Pricing

Pricing shown for information only. Your plan is confirmed after your free consultation.

Start Your Journey
HIPAA Compliant LegitScript Certified FDA-registered U.S. pharmacy Licensed U.S. Providers

Prescription products require an online consultation with a licensed healthcare provider who will determine whether treatment is appropriate.

What Is PT-141 (Bremelanotide)?

PT-141, also known as bremelanotide, is a melanocortin receptor agonist used in sexual health treatment. FDA-approved bremelanotide is indicated for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). Other uses may be considered off-label after individualized medical evaluation.

Potential Benefits

Sexual Desire Support

FDA-approved bremelanotide may help treat acquired, generalized HSDD in eligible premenopausal women.

Central Nervous System Approach

Acts on melanocortin receptors rather than primarily targeting blood flow or hormone levels.

On-Demand Treatment

Bremelanotide is used as needed rather than as a daily medication when prescribed according to the FDA-approved regimen.

Provider Oversight

Treatment is based on symptoms, cardiovascular health, medications, medical history, and individual risks.

Who Is It For?

Low sexual desire and sexual dysfunction can have hormonal, psychological, neurological, medication-related, cardiovascular, and other causes.

  • Premenopausal Women With HSDD

    FDA-approved bremelanotide is indicated for acquired, generalized HSDD that causes marked distress or interpersonal difficulty.

  • Patients With Persistent Low Sexual Desire

    Symptoms may warrant evaluation to determine the underlying cause and appropriate treatment.

  • Men With Sexual Health Concerns

    Bremelanotide use in men, including for erectile dysfunction or low sexual desire, is off-label and requires individualized evaluation.

  • Patients Seeking Provider-Guided Sexual Health Care

    Treatment requires review of cardiovascular health, medications, symptoms, and potential contraindications.

Bremelanotide is not FDA-approved to enhance sexual performance. A licensed healthcare provider will evaluate your symptoms, medical history, medications, cardiovascular health, and individual risks before recommending treatment.

How It Works

Bremelanotide activates melanocortin receptors in the central nervous system. The exact mechanism by which it improves symptoms of HSDD is not fully understood. Treatment is individualized based on diagnosis, medical history, response, and potential risks.

Potential Side Effects

PT-141 may cause side effects, and individual experiences can vary.

Common or Possible Side Effects:

  • Nausea
  • Flushing
  • Injection-site reactions
  • Headache
  • Vomiting
  • Dizziness

Important or Serious Risks:

  • Temporary increases in blood pressure
  • Temporary reductions in heart rate
  • Focal skin or gum hyperpigmentation, which may not fully resolve
  • Significant nausea or vomiting
  • Potential fetal harm during pregnancy
  • Changes in absorption of certain oral medications

Bremelanotide is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease. It may also reduce exposure to orally administered naltrexone and affect absorption of certain other oral medications. Your provider will review your cardiovascular history, medications, and other risk factors before treatment.

How to Get Started

1

Digital Assessment

Share your medical history, current symptoms, medications, cardiovascular history, and sexual wellness concerns through our secure online assessment.

2

Virtual Consultation

Meet remotely with a licensed healthcare provider who will review your information and determine whether PT-141 or another treatment may be appropriate.

3

Treatment & Delivery

If treatment is prescribed, your medication and care plan will be coordinated through the appropriate licensed pharmacy, with administration instructions and ongoing provider oversight.

See If You Qualify

Explore Other Treatment Options

Discover other provider-guided treatments available through Premier Hormone Health.

Explore Treatments

FAQs

Can I buy PT-141 online?

PT-141 may be obtained online with a valid prescription after evaluation by a licensed healthcare provider. Avoid sources offering injectable peptides for self-treatment without appropriate medical and pharmacy oversight.

How can I get a PT-141 prescription online?

A PT-141 prescription online begins with a telehealth evaluation. Your provider reviews your symptoms, medical history, medications, cardiovascular health, and potential risks before determining whether treatment is appropriate.

What is PT-141 peptide used for?

Bremelanotide is FDA-approved as Vyleesi for acquired, generalized HSDD in certain premenopausal women. Use in men, postmenopausal women, erectile dysfunction, or other sexual-health conditions is off-label.

Is PT-141 FDA-approved?

Bremelanotide is FDA-approved as Vyleesi 1.75 mg/0.3 mL subcutaneous injection for certain premenopausal women with acquired, generalized HSDD. Compounded PT-141 formulations are not FDA-approved.

Can men use PT-141?

A provider may consider bremelanotide off-label for certain men after individualized evaluation, but FDA-approved Vyleesi is not indicated for men or for erectile dysfunction.

Get Started For $99 Initial Provider Consult